Alliance for Clinical Trials in Oncology Membership Core
Official title: Alliance for Clinical Trials in Oncology Member Site Core
Funded at Alliance Nctn Foundation · NIH-11291203 · Data updated 2026-11-12
This grant supports a national cancer trials network to make it easier for patients, including teens and young adults, to access high-quality clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Alliance Nctn Foundation NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | April 17, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $2,485,410 |
| NIH project number | 2U10CA180821-12 |
| Project ID | NIH-11291203 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adolescents and young adults with cancer or those eligible for participation in Alliance trials across multiple cancer types.
✕Less likely to help
Patients not enrolled in or eligible for Alliance trials may not directly benefit from the core's activities.
What this research studies
The Membership Core coordinates many cancer trials across multiple institutions to ensure efficient patient accrual and rigorous trial conduct. It provides access to experienced oncology researchers, multidisciplinary teams, and collaborative infrastructure to support trial design, implementation, and correlative biomarker studies. The core aims to benefit patients by streamlining trial access, expanding available therapies, and improving safety monitoring and data quality for those enrolled in trials. It focuses on diverse patient populations and a wide range of cancers, including breast, CNS, and hematologic cancers, to advance better treatments and supportive care.
Why it matters
Potential benefit: If successful, patients could access more trials with better care coordination and faster results guiding treatment.
How similar studies have gone: Previous multi-institution trial networks have shown improved accrual and trial quality through centralized governance and collaboration.
Where this research is happening
-
Alliance Nctn Foundation
Chicago, United States Active
Researchers
- Principal investigator: Galanis, Evanthia — Alliance Nctn Foundation
- Study coordinator: Galanis, Evanthia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.